| |
| ’r�ã�@�çŽõŽq |
“Á’è”ñ‰c—˜Šˆ“®–@�l‚Õ‚ê‚¢‚·“Œ‹ž�@‘ã•\ |
| ƒZƒNƒ\ƒ�ƒW�[ |
| ŽáŽÒ‚Ì�«Š´�õ�ǂɊ֘A‚·‚é’mޝ‚â�«�s“®�A�«ˆÓޝ‚ÌŒ»�ó�A’r�ã�çŽõŽq�A�uŒö�O‰q�¶�v‘æ‚V‚QŠª‚U�†�A444-450, 2008 |
| ŒŸ�¸‚ð‚æ‚è—LŒø‚É‚·‚邽‚ß‚Ì‘Š’k‘Ì�§‚Ì�®”õ‚ɂ‚¢‚Ä�A’r�ã�çŽõŽq�A�u•ÛŒ’ˆã—ÉȊw�v‘æ‚T‚UŠª‚R�†�A224-229�A2007 |
| �uŽv‚¢‚±‚Ý‚Ì�«�AƒŠƒXƒL�[‚ȃZƒbƒNƒX�vŠâ”g�‘“X�@�i2011”N�j |
|
| |
| �¡‘º�@’m–¾ |
“Þ—ÇŒ§—§ˆã‰È‘åŠwŒ’�N��ôˆãŠw�u�À�@‹³Žö |
| Œö�O‰q�¶Šw |
Toshio Ogawa, Manabu Akahane, Soichi Koike, Seizan Tanabe, Tatsuhiro Mizoguchi, Tomoaki Imamura
Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study. BMJ. 2011;342:c7106.
|
Imamura T, Kanagawa Y, Ebisawa M.
A survey of patients with self-reported severe food allergies in Japan. Pediatric Allergy and Immunology. 2008 May;19(3):270-274.
|
Imamura T, Ide H, Yasunaga H.
History of public health crises in Japan.�@J Public Health Policy.�@2007 Nov;28(2):221-237.
|
|
| |
| Šâ–{�@ˆ¤‹g |
“Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†�Š�E‹³Žö |
| Š´�õ�ÇŠw�EƒEƒCƒ‹ƒXŠw |
| 1. Miyauchi, K., Curran, A.R., Long, Y., Kondo, N., Iwamoto, A., Engelman, D.M., and Matsuda, Z. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein. Retrovirology 2010, 7:95. doi:10.1186/1742-4690-7-95. E- published, November 13, 2010. |
2. Kondo, N., Miyauchi, K. Meng, F. Iwamoto, A. and Matsuda, Z.
Conformational changes of the HIV-1 envelope protein during membrane fusion were inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285:14681-14688, 2010.
|
3. 156. Koga, M., Kawana-Tachikawa, A., Heckerman, D., Odawara, T.,
Nakamura, H., Koibuchi, T., Fujii, T., Miura, T., and Iwamoto, A.
Transition of impact of HLA class I allele expression on HIV-1 plasma virus loads at a population level over time. Microbiol. Immunol. 54:196- 205, 2010.
|
|
| �› |
| ‘q“c�@‹B |
•xŽRŒ§‰q�¶Œ¤‹†�Š�@�Š’· |
| ƒEƒCƒ‹ƒXŠ´�õ�ǂ̕a—�Šw |
Kinomoto M, Yokoyama M, Sato H, Kojima A, Kurata T,Ikuta K, Sata T, Tokunaga K: Amino Acid 36 in the humana immunodeficiecy Virus Type 1 gp41 ectodomain controls fusogenic activity: Implications for the molecular mechanism of viral escape from a fusion inhibitor.
J Virol 79: 5996-6004, 2005
|
| Maeda M., Sawa H., Tobiume M., Tokunaga K., Hasegawa H., Ichinohe T., Sata T., Moriyama M., Hall�@W.W., Kurata T.and Takahashi H.:�@Tristetraprotein inhibits HIV-I production by binding to genomic RNA. Microbes and Infection 8:2647-2656, 2006 |
| Kinomoto M., Kanno T., Shimura M., Ishizaka Y., Kojima A., Kurata T., Sata T. and Tokunaga K.: All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Research 35:2955-2964, 2007 |
|
| |
| ‘ŠŠy�@—TŽq |
|
| —Õ�°Š´�õ�ÇŠw |
| “ˆ‹MŽq�C�{“¡�O“ñ�C‹ß“¡�^‹KŽq�C‘qˆä‰ØŽq�C‘ŠŠy—TŽq�C�¡ˆäŒõ�M�FŒuŒõ�y‘f–Ɖu‘ª’è–@‚É‚æ‚é�V‚µ‚¢HIV�RŒ´�R‘Ì“¯ŽžŒŸ�oŽŽ–ò�i‘æ4�¢‘ã�j‚ÌŒŸ“¢�DŠ´�õ�ÇŠw‰ïŽ�81�F562-572�C2007 |
| ’ËŒ´—DŒÈ�C‘ŠŠy—TŽq�CŠì‘½�P˜a�C“ˆ‹MŽq�C–î‰i—R—�Žq�CŠO�ì�³�¶�C‘å‹à”ü˜a�Cˆî—tŒ›”V�F‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´�õ�—�«‚Ì”D�P�E�oŽY�EˆçŽ™Žx‰‡�D“ú–{ƒGƒCƒYŠw‰ïŽ�9�F116-119�C2007�D |
Mohri S, Yoshikawa K, Sagara H, Nakajima, H�FA case of Penicillium marneffei infection in an AIDS patient the first case in Japan . Jpn J
Med Mycol 41: 23-26, 2000.
|
|
| |
| �ªŠÝ�@�¹Œ÷ |
‚Ë‚¬‚µ“à‰È�f—Ã�Š�@�Š’· |
| Š´�õ�ÇŠw |
ƒGƒCƒY�f—Âɂ¨‚¯‚éConsultation-Liaison Psychiatry�@�@�ªŠÝ�¹Œ÷�A•Û�â—²
�¸�_‰ÈŽ¡—Êw�@1990�@5;609-614�C |
�wƒGƒCƒY‚ð�f‚é�x�@�@�ªŠÝ�¹Œ÷�A”ª�XŒ[�A—k�U“T�A‹Ê�ì�d“¿‹¤’˜
’©“ú�V•·ŽÐ�i1987�j
|
|
| |
| –ž‰®�@—T–¾ |
ŒF–{‘åŠw ŒŒ‰t“à‰È�EäPŒ´•a“à‰È�EŠ´�õ–Ɖu�f—Õ” |
| Š´�õ�ÇŠw�EŒŒ‰t“à‰ÈŠw |
| Ghosh, A.K., Chapsal, B.D., Weber, I.T., and Mitsuya, H.(2008) Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance. Acc. Chem. Res. 41: 78-86. |
| Maeda, K., Das, D., Yin, P., Tsuchiya, K., Ogata-Aoki, H., Nakata, H., Norman, R., Hackney, L., Takaoka, Y., and Mitsuya, H. (2008) Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: Insights to mechanism of allosteric inhibition. J. Mol. Biol. 381:956-974. |
| Aoki, M., Venzon, D.J., Koh, Y., Aoki-Ogata, H., Miyakawa, T., Yoshimura, K., Maeda, K., and Mitsuya, H. (2009) Non-cleavage site gag mutations in amprenavir-resistant HIV-1 predispose HIV-1 to rapid acquisition of amprenavir resistance but delays development of resistance to other protease inhibitors. J. Virol. 83:3059-3068. |
|
| |
| ‹{“c�@ˆê—Y |
ƒGƒCƒY—\–h�à’c—�Ž–�AŽYŒo�V•·•Ò�WˆÏˆõ |
| •ñ“¹ |
| �uƒs�[ƒvƒ‹�EƒEƒCƒY�EƒGƒCƒY�v‘¾˜YŽŸ˜YŽÐ�i1992”N�j |
| �uƒGƒCƒY�EƒfƒCƒY�v•½–}ŽÐ�V�‘�i2000”N�j |
| �u�¢ŠE‚̓GƒCƒY‚Ƃǂ¤“¬‚Á‚Ä‚«‚½‚Ì‚©�vƒ|ƒbƒg�o”Å�i2003”N�j |
|